APA Zitierstil

Lin, Y., Li, Y., & Ma, J. (2017). Aberrant Promoter Methylation of Protocadherin8 (PCDH8) in Serum is a Potential Prognostic Marker for Low Gleason Score Prostate Cancer. Med Sci Monit.

Chicago Zitierstil

Lin, Ying-Li, Yan-Li Li, und Jian-Guo Ma. "Aberrant Promoter Methylation of Protocadherin8 (PCDH8) in Serum Is a Potential Prognostic Marker for Low Gleason Score Prostate Cancer." Med Sci Monit 2017.

MLA Zitierstil

Lin, Ying-Li, Yan-Li Li, und Jian-Guo Ma. "Aberrant Promoter Methylation of Protocadherin8 (PCDH8) in Serum Is a Potential Prognostic Marker for Low Gleason Score Prostate Cancer." Med Sci Monit 2017.

Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.